Overview
Irma Bisceglia practices practicing medicine in Rome, Italy.
Ms. Bisceglia is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Doxorubicin-Induced Cardiomyopathy, Cardiomyopathy Due to Anthracyclines, Myocarditis, and Heart Failure.
She is actively involved in clinical research, co-authoring 72 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Irma Bisceglia
Is Irma Bisceglia a top-rated expert for Doxorubicin-Induced Cardiomyopathy?
MediFind is an objective health platform that identifies experts based on real-world data. Irma Bisceglia is classified as an Distinguished expert for Doxorubicin-Induced Cardiomyopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Irma Bisceglia participate in research or clinical trials?
Yes. Irma Bisceglia has published 72 articles and abstracts on conditions like Doxorubicin-Induced Cardiomyopathy. You can view a list of Irma Bisceglia's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Cardiomyopathy Due to AnthracyclinesMs. Bisceglia isDistinguished. Learn about Cardiomyopathy Due to Anthracyclines.
- Doxorubicin-Induced CardiomyopathyMs. Bisceglia isDistinguished. Learn about Doxorubicin-Induced Cardiomyopathy.
- Advanced
- Heart FailureMs. Bisceglia isAdvanced. Learn about Heart Failure.
- MyocarditisMs. Bisceglia isAdvanced. Learn about Myocarditis.
- Experienced
- Acute Coronary SyndromeMs. Bisceglia isExperienced. Learn about Acute Coronary Syndrome.
- AtherosclerosisMs. Bisceglia isExperienced. Learn about Atherosclerosis.
- Atrial FibrillationMs. Bisceglia isExperienced. Learn about Atrial Fibrillation.
- Atrial MyxomaMs. Bisceglia isExperienced. Learn about Atrial Myxoma.
- Breast CancerMs. Bisceglia isExperienced. Learn about Breast Cancer.
- CardiomyopathyMs. Bisceglia isExperienced. Learn about Cardiomyopathy.
- Heart AttackMs. Bisceglia isExperienced. Learn about Heart Attack.
- Heart TumorMs. Bisceglia isExperienced. Learn about Heart Tumor.
- HypertensionMs. Bisceglia isExperienced. Learn about Hypertension.
- Long Haul COVIDMs. Bisceglia isExperienced. Learn about Long Haul COVID.
- Metabolic SyndromeMs. Bisceglia isExperienced. Learn about Metabolic Syndrome.
- ObesityMs. Bisceglia isExperienced. Learn about Obesity.
- PericarditisMs. Bisceglia isExperienced. Learn about Pericarditis.
- Severe Acute Respiratory Syndrome (SARS)Ms. Bisceglia isExperienced. Learn about Severe Acute Respiratory Syndrome (SARS).
- StrokeMs. Bisceglia isExperienced. Learn about Stroke.
- Type 2 Diabetes (T2D)Ms. Bisceglia isExperienced. Learn about Type 2 Diabetes (T2D).
- Venous Thromboembolism (VTE)Ms. Bisceglia isExperienced. Learn about Venous Thromboembolism (VTE).